RnRMarketResearch.com adds “Neurofibromatoses Type II - Pipeline Review, H1 2015” to its store. This report provides an overview of the Neurofibromatoses Type II 's therapeutic pipeline.

Dallas, TX -- (SBWire) -- 06/24/2015 --The report "Neurofibromatoses Type II - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Neurofibromatoses Type II, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Progressive Supranuclear Palsy and special features on late-stage and discontinued projects.

Complete report on Neurofibromatoses Type II with 18 market data tables and 12 figures, spread across 39 pages is available at http://www.rnrmarketresearch.com/neurofibromatoses-type-ii-pipeline-review-h1-2015-market-report.html .

Companies discussed in this Neurofibromatoses Type II - Pipeline Review, H1 2015 report include Arno Therapeutics, Inc., CalAsia Pharmaceuticals, Inc., Nexgenix Pharmaceuticals, LLC and Lixte Biotechnology Holdings, Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are AR-42, FRAX-597, LB-201, LB-205 and NXD-30001.

Order a purchase copy of this report @
http://www.rnrmarketresearch.com/contacts/purchase?rname=392683
(This is a premium report priced at US$2000 for a single user License.)

Featured News & Press Releases cover by this report includes:

-May 11, 2012: Arno Therapeutics Receives European Orphan Drug Designation For AR-42

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

List of Tables
Number of Products under Development for Neurofibromatoses Type II, H1 2015 7
Number of Products under Development for Neurofibromatoses Type II - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Number of Products under Investigation by Universities/Institutes, H1 2015 10
Comparative Analysis by Early Stage Development, H1 2015 11
Products under Development by Companies, H1 2015 12
Products under Investigation by Universities/Institutes, H1 2015 13
Neurofibromatoses Type II - Pipeline by Arno Therapeutics, Inc., H1 2015 14
Neurofibromatoses Type II - Pipeline by CalAsia Pharmaceuticals, Inc., H1 2015 15
Neurofibromatoses Type II - Pipeline by Nexgenix Pharmaceuticals, LLC, H1 2015 16
Neurofibromatoses Type II - Pipeline by Lixte Biotechnology Holdings, Inc., H1 2015 17
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Stage and Target, H1 2015 20
Number of Products by Stage and Mechanism of Action, H1 2015 22
Number of Products by Stage and Route of Administration, H1 2015 24
Number of Products by Stage and Molecule Type, H1 2015 25
Neurofibromatoses Type II Therapeutics - Recent Pipeline Updates, H1 2015 34
Neurofibromatoses Type II - Dormant Projects, H1 2015 36

List of Figures
Number of Products under Development for Neurofibromatoses Type II, H1 2015 7
Number of Products under Development for Neurofibromatoses Type II - Comparative Analysis, H1 2015 8
Number of Products under Development by Companies, H1 2015 9
Comparative Analysis by Early Stage Products, H1 2015 11
Assessment by Monotherapy Products, H1 2015 18
Number of Products by Top 10 Targets, H1 2015 19
Number of Products by Stage and Top 10 Targets, H1 2015 20
Number of Products by Top 10 Mechanism of Actions, H1 2015 21
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 22
Number of Products by Top 10 Routes of Administration, H1 2015 23
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 24
Number of Products by Stage and Top 10 Molecule Types, H1 2015 25

Explore more reports on Cancer therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/cancer-therapeutics

About RnRMarketResearch.com
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.